These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38512815)

  • 1. Ebola virus disease sequelae and viral persistence in animal models: Implications for the future.
    Durant O; Marzi A
    PLoS Pathog; 2024 Mar; 20(3):e1012065. PubMed ID: 38512815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop.
    Banadyga L; Zhu W; Kailasan S; Howell KA; Franaszek K; He S; Siragam V; Cheng K; Yan F; Moffat E; Cao W; Leung A; Embury-Hyatt C; Aman MJ; Qiu X
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Ebola Virus Mucosal Challenge Routes in Cynomolgus Macaques.
    Johnson DM; Brasel T; Massey S; Smith J; Garron T; Wallace S; Yu X; Beasley DW; Comer JE
    J Virol; 2023 May; 97(5):e0188822. PubMed ID: 36975793
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.
    Watson RJ; Tree J; Fotheringham SA; Hall Y; Dong X; Steeds K; Gouriet J; Salguero FJ; Burton C; Pitman J; Easterbrook L; Richards KS; Burton J; Bewley K; Bruce C; Hiscox JA; Carroll MW; Funnell SGP
    J Virol; 2021 Nov; 95(24):e0083321. PubMed ID: 34586862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing a Mouse Model for Sexual Transmission and Male Reproductive Tract Persistence of Ebola Virus.
    Clancy CS; Smart G; Rhoderick JF; O'Donnell KL; Rosenke R; Schäfer A; Marzi A
    J Infect Dis; 2023 Nov; 228(Suppl 7):S554-S558. PubMed ID: 37102262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks.
    Matson MJ; Chertow DS; Munster VJ
    Emerg Microbes Infect; 2020; 9(1):291-301. PubMed ID: 32013784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of Ebola virus in semen among Ebola virus disease survivors in Sierra Leone: A cohort study of frequency, duration, and risk factors.
    Thorson AE; Deen GF; Bernstein KT; Liu WJ; Yamba F; Habib N; Sesay FR; Gaillard P; Massaquoi TA; McDonald SLR; Zhang Y; Durski KN; Singaravelu S; Ervin E; Liu H; Coursier A; Marrinan JE; Ariyarajah A; Carino M; Formenty P; Ströher U; Lamunu M; Wu G; Sahr F; Xu W; Knust B; Broutet N;
    PLoS Med; 2021 Feb; 18(2):e1003273. PubMed ID: 33566817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Ebola Virus Persistence in Semen of Survivors in Liberia.
    Dyal J; Kofman A; Kollie JZ; Fankhauser J; Orone R; Soka MJ; Glaybo U; Kiawu A; Freeman E; Giah G; Tony HD; Faikai M; Jawara M; Kamara K; Kamara S; Flowers B; Kromah ML; Desamu-Thorpe R; Graziano J; Brown S; Morales-Betoulle ME; Cannon DL; Su K; Linderman SL; Plucinski M; Rogier E; Bradbury RS; Secor WE; Bowden KE; Phillips C; Carrington MN; Park YH; Martin MP; Aguinaga MDP; Mushi R; Haberling DL; Ervin ED; Klena JD; Massaquoi M; Nyenswah T; Nichol ST; Chiriboga DE; Williams DE; Hinrichs SH; Ahmed R; Vonhm BT; Rollin PE; Purpura LJ; Choi MJ
    Clin Infect Dis; 2023 Feb; 76(3):e849-e856. PubMed ID: 35639875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic Resonance Imaging for Monitoring of Hepatic Disease Induced by Ebola Virus: a Nonhuman Primate Proof-of-Concept Study.
    Lee JH; Calcagno C; Feuerstein IM; Solomon J; Mani V; Huzella L; Castro MA; Laux J; Reeder RJ; Kim DY; Worwa G; Thomasson D; Hagen KR; Ragland DR; Kuhn JH; Johnson RF
    Microbiol Spectr; 2023 Jun; 11(3):e0353822. PubMed ID: 37184428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-ebolavirus and Pan-filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses.
    Holtsberg FW; Shulenin S; Vu H; Howell KA; Patel SJ; Gunn B; Karim M; Lai JR; Frei JC; Nyakatura EK; Zeitlin L; Douglas R; Fusco ML; Froude JW; Saphire EO; Herbert AS; Wirchnianski AS; Lear-Rooney CM; Alter G; Dye JM; Glass PJ; Warfield KL; Aman MJ
    J Virol; 2016 Jan; 90(1):266-78. PubMed ID: 26468533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo.
    Bratcher A; Hoff NA; Doshi RH; Gadoth A; Halbrook M; Mukadi P; Musene K; Ilunga-Kebela B; Spencer D; Bramble MS; McIlwan D; Kelly JD; Mukadi D; Kingebeni PM; Ahuka S; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009566. PubMed ID: 34383755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ebola virus disease.
    Kilgore PE; Grabenstein JD; Salim AM; Rybak M
    Pharmacotherapy; 2015 Jan; 35(1):43-53. PubMed ID: 25630412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence and Sexual Transmission of Filoviruses.
    Schindell BG; Webb AL; Kindrachuk J
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30513823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active Ebola Virus Replication and Heterogeneous Evolutionary Rates in EVD Survivors.
    Whitmer SLM; Ladner JT; Wiley MR; Patel K; Dudas G; Rambaut A; Sahr F; Prieto K; Shepard SS; Carmody E; Knust B; Naidoo D; Deen G; Formenty P; Nichol ST; Palacios G; Ströher U;
    Cell Rep; 2018 Jan; 22(5):1159-1168. PubMed ID: 29386105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ebola Virus: Pathogenesis and Countermeasure Development.
    Furuyama W; Marzi A
    Annu Rev Virol; 2019 Sep; 6(1):435-458. PubMed ID: 31567063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of Ebola virus disease in children - how far have we come?
    Dixit D; Masumbuko Claude K; Kjaldgaard L; Hawkes MT
    Paediatr Int Child Health; 2021 Feb; 41(1):12-27. PubMed ID: 32894024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: Insights on Current FDA-Approved Monoclonal Antibodies Against Ebola Virus Infection.
    Tshiani Mbaya O; Mukumbayi P; Mulangu S
    Front Immunol; 2021; 12():721328. PubMed ID: 34526994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Ebola Virus Disease (EVD) in Rhesus Monkeys for Development of EVD Therapeutics.
    Warren T; Zumbrun E; Weidner JM; Gomba L; Rossi F; Bannister R; Tarrant J; Reed M; Lee E; Raymond JL; Wells J; Shamblin J; Wetzel K; Donnelly G; Van Tongeren S; Lackemeyer N; Steffens J; Kimmel A; Garvey C; Bloomfield H; Blair C; Singh B; Bavari S; Cihlar T; Porter D
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31941095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus persistence and disease recrudescence in the brains of antibody-treated nonhuman primate survivors.
    Liu J; Trefry JC; Babka AM; Schellhase CW; Coffin KM; Williams JA; Raymond JLW; Facemire PR; Chance TB; Davis NM; Scruggs JL; Rossi FD; Haddow AD; Zelko JM; Bixler SL; Crozier I; Iversen PL; Pitt ML; Kuhn JH; Palacios G; Zeng X
    Sci Transl Med; 2022 Feb; 14(631):eabi5229. PubMed ID: 35138912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review on the antagonist Ebola: A prophylactic approach.
    Khan FN; Qazi S; Tanveer K; Raza K
    Biomed Pharmacother; 2017 Dec; 96():1513-1526. PubMed ID: 29208326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.